Skip to content

13F-HR filed by Cormorant Asset Management, LP

Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 19:47:24 UTC, with 60 holding rows worth $1,489,258,905.

Accession
0001583977-26-000011
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 60 entries on the cover page, a total value of $1,489,258,905 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,489,258,905 with VALUE read as dollars as filed, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PARABILIS MEDICINES INC COM698955101Stock4,615,612$149,038,111dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW500,000$145,615,000dollars as filed
RAPPORT THERAPEUTICS INC COM75383L102Stock2,457,521$82,572,706dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM1,860,000$75,516,000dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW17,878,594$73,302,235dollars as filed
ERASCA INC COM29479A108Stock5,000,000$73,300,000dollars as filed
BLOSSOMHILL THERAPEUTICS INC095130100COM3,614,034$67,365,594dollars as filed
Adlai Nortye00704R109SPONSORED ADS3,978,229$63,651,664dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM500,000$44,025,000dollars as filed
ABIVAX SA-00370M103SPONSORED ADS425,000$42,083,500dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK800,000$39,856,000dollars as filed
Electra Therapeutics, Inc.284825106Common Stock, $0.0001 par value per share3,365,533$37,862,249dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock2,855,433$33,408,566dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock400,000$33,316,000dollars as filed
ATTOVIA THERAPEUTICS INC04987L102COM1,788,815$30,660,285dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW1,028,242$30,579,917dollars as filed
Latigo Biotherapeutics, Inc.517954103Common Stock, par value $0.0001 per share1,815,740$30,322,858dollars as filed
AGOMAB THERAPEUTICS NV00860C102SPONSORED ADS2,465,348$27,365,363dollars as filed
OPUS GENETICS INC67577R102COMMON STOCK5,500,000$26,620,000dollars as filed
CLIMB BIO INC28658R106COMMON STOCK2,106,000$24,155,820dollars as filed
FREENOME INC35661P100COMMON STOCK1,431,032$22,538,754dollars as filed
MBX BIOSCIENCES INC COM55287L101Stock375,000$21,982,500dollars as filed
BIOHAVEN LTDG1110E107COM1,510,000$20,158,500dollars as filed
ADARx Pharmaceuticals, Inc.00654F105Common Stock, par value $0.0001 per share962,898$19,200,176dollars as filed
EYEPOINT INC COM NEW30233G209Stock5,750,000$18,802,500dollars as filed
TANGO THERAPEUTICS INC87583X109COM700,000$17,465,000dollars as filed
DAMORA THERAPEUTICS INCG2646Y104COMM STK800,000$17,024,000dollars as filed
BRIDGEBIO PHARMA INC10806X102COM250,000$16,450,000dollars as filed
CUE BIOPHARMA INC22978P205COM625,285$16,176,123dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW2,344,971$15,992,702dollars as filed
BIOAGE LABS INC COM09077V100Stock2,240,605$15,885,889dollars as filed
ALUMIS INC022307102COM2,075,000$15,334,250dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM1,750,000$15,120,000dollars as filed
PHARVARIS NVN69605108COMMON STOCK450,000$14,274,000dollars as filed
HELIX ACQUISITION CORP IIIG4444S107USD CL A ORD SHS1,297,500$13,779,450dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW125,000$11,128,750dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS275,000$10,466,500dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock1,750,000$9,205,000dollars as filed
AMYLYX PHARMACEUTICALS INC03237H101COM300,000$8,730,000dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK4,500,000$8,640,000dollars as filed
INHIBRX BIOSCIENCES INC45720N103COM50,000$5,004,000dollars as filed
KAILERA THERAPEUTICS INC482931102COMMON STOCK400,000$4,568,000dollars as filed
JADE BIOSCIENCES INC008064206COM NEW300,000$4,215,000dollars as filed
IBIO INC451033708CMN3,570,000$4,212,600dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK50,000$3,930,500dollars as filed
ROIVANT SCIENCES LTDG76279101SHS100,000$3,657,000dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock75,000$3,438,000dollars as filed
ASCENDIS PHARMA A/SK08588103ORD SHS *A*15,000$3,417,450dollars as filed
Odyssey Therapeutics, Inc.67613T104COMMON STOCK125,000$2,777,500dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK100,000$2,432,000dollars as filed
BOUNDLESS BIO INC10170A100COM940,000$2,359,400dollars as filed
INSMED INC COM PAR $.01457669307Stock20,000$2,282,800dollars as filed
Braveheart Bio Inc10567X101COM70,000$1,414,000dollars as filed
Research Alliance Corp Iii Ord Shs Cl AG75226103Common Stock125,000$1,353,750dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM50,000$1,321,500dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM15,000$981,750dollars as filed
COGENT BIOSCIENCES INC19240Q201COM30,000$960,600dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY30,000$938,100dollars as filed
VAXCYTE INC COM92243G108Stock15,000$853,500dollars as filed
QUINCE THERAPEUTICS INC COM22053A305Stock5,498$170,493dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001583977-26-000011this filing2026-11-16